"Instituto Oulton es un centro de avanzada especializado en diagnóstico por imágenes y en prácticas médicas y quirúrgicas ambulatorias. El compromiso con la excelencia en el cuidado de nuestros pacientes ha hecho que, desde su fundación en 1978, el Instituto sea reconocido como modelo a seguir en sus prácticas médicas, académicas, administrativas y en la incorporación continua de alta tecnología."

During the past decade, Instituto Oulton conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Instituto Oulton" are "Coronary Artery Disease (CAD)" (1 trials) and "Nonalcoholic Steatohepatitis" (1 trials). Many other conditions were trialed in "Instituto Oulton" in a lesser frequency.

Most popular intervention types in "Instituto Oulton" are "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo to match SEL 18 mg" (1 trials), "Placebo to match SEL 6 mg" (1 trials), "Regadenoson" (1 trials), "SEL" (1 trials) and "Single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Oulton" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Oulton". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Instituto Oulton, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Oulton, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".